Volver a News
NOTICIA
GA_P advises Atrys Health on the capital increase for the acquisition of Bienzobas Salud
14 de June, 2022
Gómez-Acebo & Pombo has advised Atrys Health in a structured transaction through the sale of a package of existing shares and a capital increase to finance the acquisition of Bienzobas Salud for 75 million euros, carried out through an accelerated bookbuild offering/ an accelerated private placement procedure exclusively addressed to qualified domestic and foreign investors,, executed by Barclays Bank Ireland PLC (as Sole Global Coordinator) and Andbank España, S.A.U., Banco de Sabadell, S.A., GVC Gaesco Valores, S.V., S.A. and Renta 4 Banco, S.A. (as Co-Bookrunners), which have been advised by Linklaters.
The GA_P team was integrated by Guillermo Guerra, partner of the Corporate department, Jacobo Palanca and Emiliano Moreno, lawyers of the Corporate department and Irene Medina de Alba, lawyer of the Banking and Capital Markets department.
The GA_P team was integrated by Guillermo Guerra, partner of the Corporate department, Jacobo Palanca and Emiliano Moreno, lawyers of the Corporate department and Irene Medina de Alba, lawyer of the Banking and Capital Markets department.
More information about
Gómez-Acebo & Pombo
13 Apr, 2026 
PUBLICACIÓN
15 Sep, 2026
Sale of essential assets without shareholder approval and the enforceability of such violation against third parties
The Supreme Court (Judgment no. 881/2026 of 9 June) has held that Article 234(2) of the Companies Act is applicable by analogy in a case where a company director disposed of essential company assets without the required authorisation from the shareholders in general meeting (Art. 160(f) of the Companies Act).
15 Sep, 2026 
PUBLICACIÓN
24 Jun, 2026
Invalidity, due to shareholder oppression, of the resolution to file a director liability (to company) claim
The Supreme Court (Judgment no. 824/2026, dated 29 May) affirmed the declaration of invalidity of a company resolution to file a director liability (to company) claim, finding that it had been abusively imposed by the majority insofar as not responding to a reasonable need of the company and having been passed by the majority in its own interest and to the unjustified detriment of the minority.
24 Jun, 2026
PUBLICACIÓN
17 Feb, 2026
Squeeze-out of minority shareholders following successful mandatory takeover bid: rebuttable presumption of fair consideration
The Court of Justice of the European Union (Fifth Chamber), in its judgment of 27 November 2025 (Case C-567/24, Svema Trade), concerning the equitable price in a squeeze-out requiring minority shareholders to sell their shares to an offeror who, following a mandatory takeover bid, has acquired more than 90% of the capital carrying voting rights in the company subject of the takeover bid, states that the presumption that the price offered in the bid, in the context of such a squeeze-out of holders of securities, is equitable is rebuttable.
17 Feb, 2026
PUBLICACIÓN
15 Jan, 2026
Financial institutions’ customer services following Act 10/2025
Act 10/2025 reforms the regime governing financial institutions’ customer services and introduces a procedure for the submission, processing and resolution of complaints filed by their customers, including special provisions when such customers are consumers, such as a free helpline and the availability of channels that allow for personalised service to vulnerable consumers or people without access to certain basic financial services that are not defined in the new law.
15 Jan, 2026
PUBLICACIÓN
29 Sep, 2025
Invalidity of agreements concluded by director in breach of duty of loyalty
In Judgment no. 142/2025 of 11 April, the Madrid Provincial Court (Twenty-Eighth Chamber) addressed two issues relating to the bringing of actions for declaration of invalidity of two sale and purchase agreements concluded by a company director in breach of his duty of loyalty. On the one hand, and in view of the specific circumstances, it ruled on whether the company could formally assume the role of claimant in the dispute. On the other hand, it ruled on the importance of the fact that the disputed transactions were beneficial to the company concerned and on the possibility of a ‘tacit’ dispensation.
29 Sep, 2025
PUBLICACIÓN
15 Jul, 2025
A good transposition of the Women on Boards Directive
Ireland has incorporated the mandatory presence of 40% of female non-executive directors on the boards of listed companies as of 30 June 2026, by amending the Companies Act 2014. Unlike the legislation in Spain, the percentage has been limited to this class of directors.
15 Jul, 2025
PUBLICACIÓN
06 Mar, 2025
Calling of meeting of shareholders, abuse of rights, resistance test
Once again: despite compliance with the formal requirements of a calling of meeting of shareholders, company resolutions may be unenforceable if there is an abuse of rights in said call
06 Mar, 2025
PUBLICACIÓN
04 Mar, 2025
Rules to determine directors' remuneration: a case where Article 217(4) of the Companies Act applies
The Supreme Court applies the rules set out in Article 217(4) of the Companies Act to reach a decision concerning the contest of a board resolution that determined the remuneration of a company director.
04 Mar, 2025
PUBLICACIÓN
27 Feb, 2025
An end to rules on racial, gender and LGTBQ+ diversity on Nasdaq-listed company boards
In Alliance for Fair Board Recruitment; NCPPR v. SEC, the U.S. Court of Appeals vacates, by a one-vote margin, the Securities & Exchange Commission’s approval in 2021 of Nasdaq’s rules on board diversity for companies listed on its exchange.
27 Feb, 2025